LHCGR rs121912650: Understanding Leydig Cell Hypoplasia Variants

What each genotype means

What is the rs121912650 Variant?

The rs121912650 variant is a specific change in the DNA sequence of the LHCGR gene. In genetics, a variant like this represents a single point of difference in the genetic code compared to the most common sequence found in the human population. Because this variant is classified as ultra-rare, it is not typically found in the general population and is primarily identified in clinical settings when individuals present with specific symptoms related to reproductive development. It is categorized as a pathogenic variant in databases like ClinVar, meaning it is known to disrupt the normal function of the gene. Understanding such variants requires looking at how they alter the protein structure, which in this case, affects the body's ability to process critical reproductive hormones.

The Role of the LHCGR Gene

The LHCGR gene provides the instructions for building the luteinizing hormone/chorionic gonadotropin receptor. This receptor acts like a lock on the surface of cells, waiting for specific hormonal keys—luteinizing hormone and chorionic gonadotropin—to bind to it. In males, this receptor is essential for the development and function of Leydig cells in the testes. When these hormones bind to the receptor, they trigger the production of androgens, such as testosterone, which are vital for male sexual development before birth and during puberty. If the receptor is missing or non-functional, the body cannot respond to these signals, leading to a spectrum of conditions known as Leydig cell hypoplasia. This highlights the gene's fundamental role in human reproductive physiology.

Clinical Associations and Evidence

Research consistently associates inactivating mutations in the LHCGR gene with Leydig cell hypoplasia. The evidence for this association is considered strong in clinical genetics, as these variants directly interfere with the signaling pathways required for testosterone synthesis. In individuals with a 46,XY chromosome pattern, these mutations can lead to a range of phenotypes, from severe cases where external genitalia appear female, to milder cases involving micropenis or hypospadias. Because the condition is autosomal recessive, it typically requires two copies of an inactivating variant—either homozygous or compound heterozygous—to manifest symptoms. The clinical presentation is highly variable, reflecting the degree to which the receptor's function is impaired. Clinicians use this genetic information to better understand the underlying cause of differences in sex development (DSD).

Population Frequency and Interpretation

The rs121912650 variant is classified as ultra-rare, meaning it is found at an extremely low frequency across all global populations. It is not a common polymorphism that one would expect to see in the general public. Because of its rarity, most people will never encounter this variant. When it is identified, it is usually through targeted genetic testing for individuals experiencing specific reproductive health challenges. It is important to note that having a rare variant does not automatically imply a specific health outcome, as the context of the entire gene and the presence of other variants play a significant role. This information is intended for educational purposes and should not be used for self-diagnosis. Any concerns regarding reproductive health or genetic findings should be discussed with a qualified medical professional or genetic counselor.

Frequently asked questions

Sources & further reading

Related variants in LHCGR